期刊文献+

胃窦癌患者幽门螺旋杆菌感染率与MiR-21表达水平的相关性 被引量:4

Relationship between Helicobacter Pylori Infection Rate and Expression of MiR-21 in Patients with Gastric Antral Cancer
下载PDF
导出
摘要 目的探讨胃癌患者幽门螺旋杆菌(Helicobacter pylori,Hp)感染率与miR-21表达水平的相关性。方法2011-01/2012-01月求诊广州军区广州总医院消化内科的患者,经电子胃镜检查,活检其病变组织送病理检查,纳入诊断为胃窦癌的患者91例,慢性浅表性胃窦炎患者95例。两组患者均行13 C呼气试验,明确Hp感染情况。胃窦癌患者转外科行手术根治,术中留取病变组织及癌旁组织,应用实时荧光定量聚合酶链反应(real time fluorescence qua-ntitativepolymerase chain reaction,qRT-PCR)进行miR-21表达水平检测。结果①胃癌患者Hp感染率为79.12%,高于慢性浅表性胃窦炎组的66.32%,差异有统计学意义(P=0.001);②胃癌患者的胃癌组织miR-21表达水平较癌旁组织高,差异有统计学意义(P=0.000);③感染Hp的胃癌患者miR-21表达水平较Hp阴性患者高,差异具有统计学意义(P=0.009)。结论Hp感染、miR-21高表达可能共同参与胃癌的发生、发展,二者存在相关性。 Objective To study the relationship between the expression of miR-21 and the infection rate of Helicobacter pylori(Hp) in patients with gastric antral cancer.Methods A total of 91 patients diagnosed as having gastric cancer by electronic gastroscopy and pathological examination and 95 patients with chronic superficial gastritis who visited Guangzhou General Hospital of Guangzhou Command during January 2011 to January 2012 were studied.13C urea breath tests were used to investigate the Hp infection.Quantitative real time fluorescence qua-ntitative polymerase chain reaction(qRT-PCR)was performed to detect the miR-21 expression level of the tissue obtained during operations.Results The infection rate of Hp in gastric cancer group was 79.12%,which was significantly higher than 66.32% in the chronic superficial gastritis group(P=0.001).The expression of miR-21 in gastric carcinoma tissue was significantly higher than that in the tumor-adjacent normal colorectal tissue(P=0.000).The expression of miR-21 in gastric carcinoma of Hp(+) patients was significantly higher than that in the Hp(-) patients(P=0.009).Conclusion Hp infection and high level of miR-21 may contribute to the occurrence and development of gastric cancer.
出处 《华南国防医学杂志》 CAS 2012年第5期434-437,共4页 Military Medical Journal of South China
基金 广东省科技计划项目(2011B031800317) 广东省大学生创新实验项目(1057212046) 广州中医药大学科技创新研究项目(yyyx1023)
关键词 胃癌 MICRORNA MIR-21 幽门螺杆菌 Gastric cancer MicroRNA MiR-21 Helicobacter pylori
  • 相关文献

参考文献24

  • 1Chen J, Bu XL, Eang QY,et al. Decreasing seropravelencc of Hell cobacter pylori infection during 1993-2003 in Guangzhou, southern China[J]. Helicobacter, 2007,12 : 164-169.
  • 2Flynt AS, Lai EC. Biological principles of microRNA medialed regulation: shared themes amid diversity[[J]. Nat Rev Genetics, 2(1(18,9(11 ) : 831-842.
  • 3Stenvang J, Petri A, Lindow M, et aL. Inhibition of microRNA function bv antimiR olionucleoddes[J]. Silence, 2{112,3 ( I )= 1.
  • 4李立平,吴炜景,吴伟洪,赵亚刚.MiR-21、幽门螺旋杆菌CagA与胃癌相关性研究进展[J].华南国防医学杂志,2012,26(4):389-391. 被引量:14
  • 5谢川,徐丽瑶,刘龚玫子,杨桢,吕农华.miRNA与幽门螺杆菌致病的关系[J].世界华人消化杂志,2011,19(21):2257-2261. 被引量:1
  • 6张发云,杨真威,李国明,梁伟.幽门螺杆菌与2005年诺贝尔医学奖[J].生物化学与生物物理进展,2005,32(11):1016-1019. 被引量:16
  • 7Carthew RW, Sontheimer [J. Origins and mechanisms of miRNAs and siRNAs[[J]. Cell,2009,136(4):642 655.
  • 8Stenvang J, Petri A, Lindow M, et al. Inhibition of microRNA function by antimiR oligonucleotides[J]. Silence, 2012,3 ( 1 ) : 1.
  • 9Wu WK, Lee CW, Cho CH, et al. MicroRNA dysregulation in gas- tric cancer: a new player enters the game[[J]. Oncogene, 2010,29(43): 5761- 5771.
  • 10Chan SH, Wu CW, Li AF, et al. miR-21 microRNA expression in human gastric carcinomas and its clinical association[J]. Antican cer Res,2008,28(2A) :907- 911.

二级参考文献58

  • 1Takafumi Ando,Yasuyuki Goto,Osamu Maeda,Osamu Watanabe,Kazuhiro Ishiguro,Hidemi Goto.Causal role of Helicobacter pylori infection in gastric cancer[J].World Journal of Gastroenterology,2006,12(2):181-186. 被引量:29
  • 2汤净,周元平.幽门螺杆菌的毒力基因研究进展[J].中国热带医学,2007,7(1):118-121. 被引量:3
  • 3Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61:69-90.
  • 4Wu WK, Lee CW, Cho CH, Fan D, Wu K, Yu J, Sung JJ. MicroRNA dysregulation in gastric cancer:a new player enters the game. Oncogene 2010; 29:5761-5771.
  • 5Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1:1311-1315.
  • 6Honda S, Fujioka T, Tokieda M, Satoh R, Nishizono A, Nasu M. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res 1998; 58:4255-4259.
  • 7Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75:843-854.
  • 8Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR, Ruvkun G. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000; 403:901-906.
  • 9Berezikov E, van Tetering G, Verheul M, van de Belt J, van Laake L, Vos J, Verloop R, van de Wetering M, Guryev V, Takada S, van Zonneveld AJ, Mano H, Plasterk R, Cuppen E. Many novel mammalian microRNA candidates identified by extensive cloning and RAKE analysis. Genome Res 2006; 16:1289-1298.
  • 10Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH, Kim VN. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004; 23:4051-4060.

共引文献30

同被引文献48

  • 1成虹,胡伏莲,李江.幽门螺杆菌耐药性对其根除治疗影响的研究[J].中华医学杂志,2006,86(38):2679-2682. 被引量:97
  • 2无,吴云林.上海不同等级10个医疗机构早期胃癌的筛选结果比较[J].中华消化内镜杂志,2007,24(1):19-22. 被引量:85
  • 3中华医学会消化病学分会幽门螺杆菌学组/幽门螺杆菌科研协作组.第三次全国幽门螺杆菌感染若干问题共识报告(2007年8月庐山)[J].胃肠病学,2008,13:42-46.
  • 4胡伏莲.消化性溃疡[M]∥萧树东,许国铭.中华胃肠病学.北京:人民卫生出版社,2008:350-373.
  • 5CHEON J H, KIM N, LEE DH, et al. Trial of moxifloxacin - contai- ning triple therapy after initial and second -line treatment failures for helicobactor pylori infection [ J ]. Korean J Gastroenterol, 2005, 45(2) :111.
  • 6SANCHEZJ E, SAENZ N G, RINCON M R, et al. Susceptibility of Hell - cobacter py[ori to mupirocin, oxazolidinones, quinupristin/ Dalfopristin and new quinolones [ J ]. J Antimicrob Chemother, 2000,46(2) :283 -285.
  • 7VAIRAD,ZULLOA, VAKILN,et al. Sequential therapy standard triple - drug therapy for Helicobacrer pylori eradieation : arandomized trial[ J ]. Ann Intern Med,2007,146 ( 8 ) :556 - 563.
  • 8PILOTTO A.Helicobacter pylori-associated peptic ulcer diseasein older patients:current management strategies[J].Drugs Aging,2001,18(7):487-494.
  • 9MURAKAMI M,SAITA H,TAKAHASHI Y,et al.Therapeuticeffects of lansoprazole on peptic ulcers in elderly patients[J].JClin Gastroenterol,1995,20(Suppl2):S79-S82.
  • 10PILOTTO A,DI MARIO F,FRANCESCHI M,et al.Cure of Heli-cobacter pylori infection in the elderly:effects of eradication ongastritis and serological markers[J].Aliment Pharmacol Ther,1996,10(6):1021-1027.

引证文献4

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部